Candida biofilms on implanted biomaterials: a clinically significant problem.

In recent years there has been an increasing appreciation that microbial biofilms are ubiquitous, which has resulted in a number of studies on infectious diseases from a biofilm perspective. Biofilms are defined as structured microbial communities that are attached to a surface and encased in a matrix of exopolymeric material. A wide range of biomaterials used in clinical practice have been shown to support colonization and biofilm formation by Candida spp., and the increase in Candida infections in the last decades has almost paralleled the increase and widespread use of a broad range of medical implant devices, mainly in populations with impaired host defenses. Formation of Candida biofilms has important clinical repercussions because of their increased resistance to antifungal therapy and the ability of cells within biofilms to withstand host immune defenses. Further recognition and understanding of the role of Candida biofilms in human infection should help in the clinical management of these recalcitrant infections.

[1]  M. Dasgupta,et al.  Biofilms and Infection in Dialysis Patients , 2002, Seminars in dialysis.

[2]  B. Lytle,et al.  Surgical and long-term antifungal therapy for fungal prosthetic valve endocarditis. , 1995, The Annals of thoracic surgery.

[3]  H. K. Schutte,et al.  Microflora on explanted silicone rubber voice prostheses: taxonomy, hydrophobicity and electrophoretic mobility. , 1994, The Journal of applied bacteriology.

[4]  B. Wickes,et al.  Characteristics of biofilm formation by Candida albicans. , 2001, Revista iberoamericana de micologia.

[5]  M. Ghannoum,et al.  Mechanism of Fluconazole Resistance in Candida albicans Biofilms: Phase-Specific Role of Efflux Pumps and Membrane Sterols , 2003, Infection and Immunity.

[6]  P. Saip,et al.  Totally implantable venous-access ports: local problems and extravasation injury. , 2002, The Lancet. Oncology.

[7]  J. A. Perry,et al.  Urinary candidiasis: A prospective study in hospital patients , 2004, Urological Research.

[8]  G. Baillie,et al.  Iron-Limited Biofilms of Candida albicans and Their Susceptibility to Amphotericin B , 1998, Antimicrobial Agents and Chemotherapy.

[9]  J. Crump,et al.  Intravascular Catheter-Associated Infections , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[10]  S. Hawser Comparisons of the susceptibilities of planktonic and adherent Candida albicans to antifungal agents: a modified XTT tetrazolium assay using synchronised C. albicans cells. , 1996, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[11]  David S. Jones,et al.  Implications of endotracheal tube biofilm for ventilator-associated pneumonia , 1999, Intensive Care Medicine.

[12]  A. Gristina,et al.  Biomaterial-centered infection: microbial adhesion versus tissue integration. , 1987, Science.

[13]  P. François,et al.  Role of Plasma and Extracellular Matrix Proteins in the Physiopathology of Foreign Body Infections , 1998, Annals of vascular surgery.

[14]  R. Donlan,et al.  Biofilms: Microbial Life on Surfaces , 2002, Emerging infectious diseases.

[15]  Ghannoum Ma Susceptibility testing of fungi and correlation with clinical outcome. , 1997 .

[16]  N. Khardori,et al.  Biofilms in device-related infections , 1995, Journal of Industrial Microbiology.

[17]  B. Wickes,et al.  Biofilm Formation by Candida dubliniensis , 2001, Journal of Clinical Microbiology.

[18]  M. Ghannoum,et al.  Antifungal Resistance of Candidal Biofilms Formed on Denture Acrylic in vitro , 2001, Journal of dental research.

[19]  K. Lewis,et al.  Riddle of Biofilm Resistance , 2001, Antimicrobial Agents and Chemotherapy.

[20]  B. Young,et al.  Intra amniotic candidiasis. Case report and meta-analysis of 54 cases , 1999, Journal of perinatal medicine.

[21]  L. J. Douglas,et al.  Medical importance of biofilms in Candida infections. , 2002, Revista iberoamericana de micologia.

[22]  Y. Carmeli,et al.  Risk factors for nosocomial candiduria due to Candida glabrata and Candida albicans. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  B. Wickes,et al.  Inhibition of Candida albicans Biofilm Formation by Farnesol, a Quorum-Sensing Molecule , 2002, Applied and Environmental Microbiology.

[24]  H. Giamarellou Nosocomial cardiac infections. , 2002, The Journal of hospital infection.

[25]  Betsy Foxman,et al.  Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. , 2002, The American journal of medicine.

[26]  J. Costerton,et al.  Bacterial biofilms: a common cause of persistent infections. , 1999, Science.

[27]  A. Hanssen,et al.  Delayed reimplantation arthroplasty for candidal prosthetic joint infection: a report of 4 cases and review of the literature. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  B. Wickes,et al.  Biofilms of Candida albicans and their associated resistance to antifungal agents. , 2001, American clinical laboratory.

[29]  G. Baillie,et al.  Effect of Growth Rate on Resistance ofCandida albicans Biofilms to Antifungal Agents , 1998, Antimicrobial Agents and Chemotherapy.

[30]  Y. Hang,et al.  Staged reimplantation of total knee arthroplasty after Candida infection. , 2001, The Journal of arthroplasty.

[31]  J. Beney,et al.  The direct cost and incidence of systemic fungal infections. , 2002, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[32]  B. Wickes,et al.  Standardized Method for In Vitro Antifungal Susceptibility Testing of Candida albicansBiofilms , 2001, Antimicrobial Agents and Chemotherapy.

[33]  B. Wickes,et al.  In Vitro Pharmacodynamic Properties of Three Antifungal Agents against Preformed Candida albicans Biofilms Determined by Time-Kill Studies , 2002, Antimicrobial Agents and Chemotherapy.

[34]  T. Inglis,et al.  Tracheal tube biofilm as a source of bacterial colonization of the lung , 1989, Journal of clinical microbiology.

[35]  G. Reid,et al.  Microbial Biofilms: Their Development and Significance for Medical Device—Related Infections , 1999, Journal of clinical pharmacology.

[36]  T. Inglis,et al.  Evidence for dynamic phenomena in residual tracheal tube biofilm. , 1993, British journal of anaesthesia.

[37]  R. Koerner Contribution of endotracheal tubes to the pathogenesis of ventilator-associated pneumonia. , 1997, The Journal of hospital infection.

[38]  S. Challacombe,et al.  Denture plaque and adherence of Candida albicans to denture-base materials in vivo and in vitro. , 1999, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[39]  P. Gilbert,et al.  Biofilm Susceptibility to Antimicrobials , 1997, Advances in dental research.

[40]  D. Sofianou,et al.  Fungal peritonitis complicating peritoneal dialysis during an 11-year period: report of 46 cases. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  R. D. McCormick,et al.  Guidelines for the prevention of intravascular catheter-related infections. , 2002, Infection control and hospital epidemiology.

[42]  I. Raad,et al.  Intravascular-catheter-related infections , 1998, The Lancet.

[43]  I. Raad Management of intravascular catheter-related infections. , 2000, The Journal of antimicrobial chemotherapy.

[44]  Á. Montero,et al.  Candida Infection of Cerebrospinal Fluid Shunt Devices: Report of Two Cases and Review of the Literature , 2000, Acta Neurochirurgica.

[45]  L. J. Douglas,et al.  Resistance of Candida albicans biofilms to antifungal agents in vitro , 1995, Antimicrobial agents and chemotherapy.

[46]  J. Pemán,et al.  Candidemia at a Tertiary-Care Hospital: Epidemiology, Treatment, Clinical Outcome and Risk Factors for Death , 2002, European Journal of Clinical Microbiology and Infectious Diseases.

[47]  J. Smith,et al.  In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872) , 1997, Antimicrobial agents and chemotherapy.

[48]  J. Costerton,et al.  Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms , 2002, Clinical Microbiology Reviews.

[49]  Mahmoud A. Ghannoum,et al.  Biofilm Formation by the Fungal PathogenCandida albicans: Development, Architecture, and Drug Resistance , 2001, Journal of bacteriology.

[50]  M. Ghannoum,et al.  Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Labora , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[51]  J. Graybill,et al.  In Vitro Activity of Caspofungin against Candida albicans Biofilms , 2002, Antimicrobial Agents and Chemotherapy.

[52]  J. Tsai,et al.  Evaluation of infectious complications of the implantable venous access system in a general oncologic population. , 2003, American journal of infection control.

[53]  Douglas Lj,et al.  Candida biofilms and their susceptibility to antifungal agents. , 1999 .

[54]  L. Mermel,et al.  Guidelines for the management of intravascular catheter-related infections. , 2001, Infection control and hospital epidemiology.

[55]  Gordon Ramage,et al.  The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans. , 2002, FEMS microbiology letters.

[56]  B. Wickes,et al.  Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. , 2002, The Journal of antimicrobial chemotherapy.

[57]  J. Sobel,et al.  Nosocomial candiduria: a review. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[58]  S. Ell,et al.  Candida – ‘the cancer of silastic’ , 1996, The Journal of Laryngology & Otology.

[59]  B. Belohradsky,et al.  Treatment of Candida albicans Endocarditis: Case Report and a Review , 2003, Infection.

[60]  G. Baillie,et al.  Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. , 2000, The Journal of antimicrobial chemotherapy.

[61]  G. Baillie,et al.  Production of extracellular matrix by Candida albicans biofilms. , 1998, Journal of medical microbiology.

[62]  K. P. Hui,et al.  Structural features of tracheal tube biofilm formed during prolonged mechanical ventilation. , 1995, Chest.

[63]  B. C. Webb,et al.  Candida-associated denture stomatitis. Aetiology and management: a review. Part 2. Oral diseases caused by Candida species. , 1998, Australian dental journal.

[64]  R. M. Donlan,et al.  Biofilms and device-associated infections. , 2001, Emerging infectious diseases.

[65]  W. Chaffin,et al.  Cell Wall and Secreted Proteins ofCandida albicans: Identification, Function, and Expression , 1998, Microbiology and Molecular Biology Reviews.

[66]  J. Costerton,et al.  Bacterial biofilms in nature and disease. , 1987, Annual review of microbiology.

[67]  D. Andes,et al.  Development and Characterization of an In Vivo Central Venous Catheter Candida albicans Biofilm Model , 2004, Infection and Immunity.

[68]  C. Mateus,et al.  Adherence of Candida albicans to Silicone Induces Immediate Enhanced Tolerance to Fluconazole , 2004, Antimicrobial Agents and Chemotherapy.

[69]  B. Wickes,et al.  Denture stomatitis: a role for Candida biofilms. , 2004, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[70]  J. Lopez-Ribot,et al.  Candida Biofilms: an Update , 2005, Eukaryotic Cell.

[71]  M. Ghannoum,et al.  Antifungal Susceptibility of Candida Biofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins , 2002, Antimicrobial Agents and Chemotherapy.

[72]  M. Ghannoum,et al.  Comparison of Biofilms Formed by Candidaalbicans and Candidaparapsilosis on Bioprosthetic Surfaces , 2002, Infection and Immunity.

[73]  J. Bradley,et al.  The treatment of Candida albicans shunt infections , 2000, Child's Nervous System.

[74]  D. M. Walker,et al.  Denture stomatitis: a review. , 1987, Journal of oral rehabilitation.

[75]  R. Donlan Biofilm formation: a clinically relevant microbiological process. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[76]  L. J. Douglas,et al.  Biofilm formation by Candida species on the surface of catheter materials in vitro , 1994, Infection and immunity.

[77]  C. Beck-Sague,et al.  Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. , 1993, The Journal of infectious diseases.

[78]  L. J. Douglas,et al.  Candida biofilms and their role in infection. , 2003, Trends in microbiology.